Clinical Trial Update: HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT) [Phase 2]

View source ↗

Summary

Phase 2 TOMCAT trial evaluating hepatic arterial infusion floxuridine (HAI-Floxuridine) or SIRT, combined with gemcitabine and oxaliplatin (Gemox), for intrahep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• HAI-Floxuridine (floxuridine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Intrahepatic Cholangiocarcinoma, Chemotherapy Effect | Phase 2 | Status: RECRUITING